F/M Investments’s GSK GSK Stock Holding History

F/M Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Sell	15,772 -88	-0.6%	-$4.65K	0.04%	211
2026 Q1	$875K	Sell	15,860 -28,427	-64%	-$1.54M	0.06%	176
2025 Q4	$2.17M	Sell	44,287 -2,199	-5%	-$103K	0.08%	228
2025 Q3	$2.01M	Sell	46,486 -1,283	-3%	-$50.1K	0.08%	245
2025 Q2	$1.83M	Buy	47,769 +2,890	+6%	+$110K	0.07%	252
2025 Q1	$1.74M	Sell	44,879 -635	-1%	-$23.2K	0.07%	246
2024 Q4	$1.54M	Buy	45,514 +7,078	+18%	+$255K	0.06%	252
2024 Q3	$1.55M	Buy	38,436 +6,284	+20%	+$257K	0.05%	236
2024 Q2	$1.24M	Buy	+32,152	New	+$1.35M	0.04%	244

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

F/M Investments's GSK Position: Q2 2026 in Review

F/M Investments reduced its GSK (GSK) stake by 0.55% in Q2 2026, selling an estimated $4.65K and leaving 15,772 shares worth $827K. The position accounts for 0.04% of the portfolio, ranked #211.

F/M Investments first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.17M in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

F/M Investments held 15,772 shares of GSK worth $827K as of Q2 2026.
F/M Investments sold 88 GSK shares in Q2 2026, an estimated $4.65K.
GSK made up 0.04% of F/M Investments's portfolio in Q2 2026, its #211 holding.
F/M Investments first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
F/M Investments's GSK position peaked at $2.17M in Q4 2025.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.